Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziying Gong

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cancer Letters|February 17, 2020
Next-generation sequencing in thymic epithelial tumors uncovered novel genomic aberration sites and strong correlation between TMB and MSH6 single nucleotide variationsKai Chen, Jiaming Che, Xianfei Zhang, et al.
Clinical Genetics|November 8, 2022
PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patientsJun Yao, Qing You, Xin Zhang, et al.
Cancer Research and Treatment|April 28, 2023
Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal CancerHuan Peng, Jun Ying, Jia Zang, et al.
Respiratory Research|January 18, 2024
Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutationsWuwu Ding, Pengmin Yang, Xiaokai Zhao, et al.
American Journal of Cancer Research|March 8, 2024
Clinical implications of PD-L1 expression and pathway-related molecular subtypes in advanced Asian colorectal cancer patientsQingqing Qiu, Dan Tan, Qiaofeng Chen, et al.
Frontiers in Oncology|April 8, 2021
Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung CancerXinyu Zhang, Chun Li, Maosong Ye, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2022
FAT1 and MSH2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic TreatmentChenliang Zhou, Yong Sun, Ziying Gong, et al.
Frontiers in Immunology|June 16, 2025
Decoding the molecular landscape: HER2 and PD-L1 in advanced gastric cancerJun Yao, Qiang Sun, Han Wu, et al.
Scientific Reports|December 23, 2022
Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinomaJun Zhang, Lidong Xu, Jun Gao, et al.
NPJ Precision Oncology|August 22, 2025
Molecular characterization and prognostic implications of KRAS mutations in pancreatic cancer patients: insights from multi-cohort analysisYubo Jiang, Gang Mai, Xiaokai Zhao, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer Letters|February 17, 2020
Next-generation sequencing in thymic epithelial tumors uncovered novel genomic aberration sites and strong correlation between TMB and MSH6 single nucleotide variationsKai Chen, Jiaming Che, Xianfei Zhang, et al.
Clinical Genetics|November 8, 2022
PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patientsJun Yao, Qing You, Xin Zhang, et al.
Cancer Research and Treatment|April 28, 2023
Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal CancerHuan Peng, Jun Ying, Jia Zang, et al.
Respiratory Research|January 18, 2024
Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutationsWuwu Ding, Pengmin Yang, Xiaokai Zhao, et al.
American Journal of Cancer Research|March 8, 2024
Clinical implications of PD-L1 expression and pathway-related molecular subtypes in advanced Asian colorectal cancer patientsQingqing Qiu, Dan Tan, Qiaofeng Chen, et al.
Frontiers in Oncology|April 8, 2021
Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung CancerXinyu Zhang, Chun Li, Maosong Ye, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2022
FAT1 and MSH2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic TreatmentChenliang Zhou, Yong Sun, Ziying Gong, et al.
Frontiers in Immunology|June 16, 2025
Decoding the molecular landscape: HER2 and PD-L1 in advanced gastric cancerJun Yao, Qiang Sun, Han Wu, et al.
Scientific Reports|December 23, 2022
Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinomaJun Zhang, Lidong Xu, Jun Gao, et al.
NPJ Precision Oncology|August 22, 2025
Molecular characterization and prognostic implications of KRAS mutations in pancreatic cancer patients: insights from multi-cohort analysisYubo Jiang, Gang Mai, Xiaokai Zhao, et al.
Pageof 3